IDH2 and acute myeloid leukemia: A variety of human cancers, including AML [92-94], show recurrent missense mutations in IDH1 and IDH2 that endow the mutant protein with the ability to synthesize 2-hydroxyglutarate (2HG) from αKG (Table 2).